Literature DB >> 35288813

One-Way Intestinal Perfusion of PVP/VA-Poloxamer 188-Curcuma longa L. Extract Solid Dispersion in Rats In Vivo and Its Effect on HSC-T6 Cell Proliferation.

Jie Gao1, Yi Shi1, Yunfeng Han1, Xi Tang1, Ruohong Bi1, Lin Pan1, Xianrong Lai2,3.   

Abstract

Turmeric was the dried rhizome of Curcuma longa L., and its extract had important pharmacological effects such as anti-tumor, cholagogic, and antioxidant. However, curcuma extract had poor water solubility and low bioavailability, which had become the main limiting factor for its clinical application. The purpose of this study was to prepare PVP/VA-Poloxamer-188-curcuma extract solid dispersion (PAP-CSD) to improve the solubility and bioavailability of the curcuma extract. The intestinal absorption mechanism of solid dispersion of this extract was studied by one-way intestinal perfusion in rats. PAP-CSD,PVP/VA-curcuma extract solid dispersion (PA-CSD) and Poloxamer-188-curcuma extract solid dispersion (P-CSD) was able to improve the intestinal absorption of the curcuma extract (P < 0.05), and PAP-CSD (combined use of two carriers) was better than that of PA-CSD and P-CSD. CCK8 method was used to investigate the effects of the curcuma extract and PAP-CSD on the proliferation of hepatic stellate cells (HSC)-T6 cells. The inhibitory effect of PAP-CSD on the proliferation of HSC-T6 cells, related to the p38 MAPK pathway, was better than that of the curcuma extract.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  HSC–T6; PVP/VA; curcuma extracts; in vivo intestinal absorption; poloxamer–188; solid dispersion

Mesh:

Substances:

Year:  2022        PMID: 35288813     DOI: 10.1208/s12249-022-02228-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  1 in total

1.  Analysis of the tumoricidal and anti-cachectic potential of curcumin.

Authors:  Christopher Oelkrug; Christina Marie Lange; Elisabeth Wenzel; Stephan Fricke; Martin Hartke; Jacinta Simasi; Andreas Schubert
Journal:  Anticancer Res       Date:  2014-09       Impact factor: 2.480

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.